Kula Investments »

Arrowhead Pharmaceuticals shares owned by Kula Investments

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Kula Investments from 13F filings

Historical chart of Kula Investments investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Kula Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Kula Investments

Quarter filed Position value Share count Share price at filing
2023-03-31 $732k 29k 25.40

More positions owned by Kula Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
W.R. Berkley Corporation (WRB)
General Motors Company (GM)
Western Union Company (WU)
NetApp (NTAP)
Allstate Corporation (ALL)
Hilton Worldwide Holdings (HLT)
ConocoPhillips (COP)
Abbott Laboratories (ABT)
Genuine Parts Company (GPC)
Union Pacific Corporation (UNP)
Marriott Intl Cl A (MAR)
Mastercard Incorporated Cl A (MA)
Johnson & Johnson (JNJ)
Las Vegas Sands (LVS)

View all positions for Kula Investments

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
FMR
Slate Path Capital
T. Rowe Price Investment Management
Geode Capital Management
Siren
Ubs Global Asset Management Americas
Jpmorgan Chase & Co
Northern Trust
Citadel Advisors
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Arrowhead Pharmaceuticals